Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fuji Keizai Estimates Japan’s Generic Drug Market To Grow 17.5 percent In 2010

This article was originally published in PharmAsia News

Executive Summary

Tokyo based market research company Fuji Keizai estimated the generic drug market in Japan will grow by 17.5 percent to ¥359.7 billion in 2010. Generic drugs will account for 5.2 percent of the prescription drug market. Reasons cited by the company include increased promotion in generic drug prescriptions among national hospitals, implementation of a diagnostic procedure combined payment system and the change in prescription forms. Fuji further noted that due to the expansion of DPC system, the use of generic injection products are increasing and the upward trend will continue. In terms of drug categories, Fuji estimates that hypertension, schizophrenia and diabetic drugs are among the generics that will grow the fastest. (Click here for more - Japanese language
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC069881

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel